Econ One is a leading economic consulting firm with expertise in the Pharmaceutical industry. With in-depth industry knowledge, our team of economists and consultants addresses critical issues that impact the pharmaceutical industry, such as generic price competition, pay-for-delay schemes, Hatch Waxman Act claims, price-fixing, market power, and cartel behavior. We have a proven track record of assisting clients with class certification and damages in pharma cases. Additionally, our international arbitration team brings global experience to pharmaceutical-related matters.
Our economic analyses and expert testimony are invaluable in cases involving generic price competition, market manipulation, contract disputes, and more. By delivering thorough economic analyses and strategic advice, we assist clients in dealing with legal intricacies related to the pharmaceutical industry.